WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Tyrogenex Inc., a company focused on an oral, multi-kinase angiogenesis inhibitor, is pleased to announce that Sheridan G. Snyder, President and Chief Executive Officer, will present at BIO National Venture Conference on Tuesday, March 31, 2009 at 2:20 PM in Boston, Massachusetts.
